Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spero Therapeutics Inc (NQ: SPRO )

1.380 +0.020 (+1.47%)
Streaming Delayed Price Updated: 12:18 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 219,526
Open 1.390
Bid (Size) 1.380 (62)
Ask (Size) 1.390 (15)
Prev. Close 1.360
Today's Range 1.350 - 1.405
52wk Range 0.6801 - 9.000
Shares Outstanding 51,776,053
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Earnings Outlook For Spero Therapeutics
 
Via Benzinga
Earnings Outlook For Spero Therapeutics
Spero Therapeutics (NASDAQ:SPRO) is set to give its latest quarterly earnings report on Monday, 2022-11-14. Here's what investors need to know before the announcement. Analysts estimate that Spero... 
Via Benzinga

Performance

YTD
-20.69%
-20.69%
1 Month
-19.30%
-19.30%
3 Month
-14.29%
-14.29%
6 Month
+58.57%
+58.57%
1 Year
-83.80%
-83.80%

More News

Read More
How Is The Market Feeling About Spero Therapeutics?
Via Benzinga
EXCLUSIVE: Top 10 Stocks Searched On Benzinga Pro In September: Where Do Tesla, Apple, Bed Bath & Beyond Rank?
Via Benzinga
This Analyst Slashes PT On Lyft By 68%, Plus Telsey Advisory Group Predicts $125 For Nike
Via Benzinga
Earnings Scheduled For November 14, 2022
Via Benzinga
Short Volatility Alert: Spero Therapeutics, Inc.
Via Benzinga
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
Via Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Via Benzinga
Dow Turns Higher; Crude Oil Rises 0.7%
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks Keep Sinking As Wall Street Comes To Terms With Fed Hike
Via Talk Markets
Spero Therapeutics (NASDAQ: SPRO) Enters into Exclusive Licensing Agreement with GSK (NYSE: GSK) for the Commercialization of Tebipenem HBr
Via Spotlight Growth
Exposures Product Safety
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Nasdaq Drops Over 100 Points; Spero Therapeutics Shares Spike Higher
Via Benzinga
How Is The Market Feeling About Spero Therapeutics?
Via Benzinga
Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement
Via InvestorPlace
Top Financial Media Stories Thursday, September 22: Facebook Sued For Bypassing Apple Privacy Rules, Walmart Slows Hiring Plans Ahead Of Holiday Season, China Blames US For Northwestern Polytechnical University Hack And More..
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
US Stocks Could Remain Jittery Thursday Over Fed Rate Hike As S&P 500, Nasdaq Futures See Volatility — McDonald's In Focus
Via Benzinga
Spero Therapeutics Stock More Than Doubles On GSK Pact For Its Lead Antibiotic
Via Benzinga
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
Via Benzinga
Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.